As previously discussed, this pathway might be activated by chromosome 19q CNV (mainly in thymomas) or by a mutation in PTEN, PIK3CA, or NF1 (in both thymomas and thymic carcinomas) [5,7]. This evidence concerns the gene PTEN and thymoma.